Therefore, there is evidence supporting the conclusion that H19 acts as an oncogene in thyroid cancer, at least in part via activation of the PI3K/AKT pathway, in order to enhance the pro-survival properties of thyroid cancer cells. This evidence concerns the gene H19 and thyroid cancer.